Skip to main content
logo
Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.650
-0.030 (-0.82%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Bicycle Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
61.2172.5935.2826.9814.4611.7
Revenue Growth
217.44%105.77%30.76%86.52%23.65%12.58%
Gross Profit
-127.85-156.5-129.59-120.68-67.15-33.18
Operating Income
-206.1-242.87-208.77-189.95-116.65-65.62
Net Income
-190.41-218.96-169.03-180.66-112.72-66.82
Earnings Per Share
-2.74-3.16-2.90-5.08-3.80-2.67
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
510.05628.11879.52526.42339.15438.68
Total Debt
14.6616.859.4944.9644.3344.34
Net Cash (Debt)
495.39611.26870.03481.47294.83394.34
Net Cash Growth
-30.64%-29.74%80.70%63.30%-25.24%228.03%
Net Cash Per Share
7.128.8214.9513.539.9415.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-206.05-249.68-164.72-60.63-86.11-14.79
Capital Expenditures
-2.23-2.35-1.24-2.93-18.99-2.03
Free Cash Flow
-208.28-252.03-165.96-63.56-105.1-16.82
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-208.89%-215.60%----283.69%
Operating Margin
-336.74%-334.59%-591.84%-704.13%-806.56%-560.98%
Pretax Margin
-308.28%-301.45%-492.69%-664.32%-789.88%-585.47%
Profit Margin
-311.11%-301.66%-479.18%-669.72%-779.35%-571.25%
FCF Margin
-340.29%-347.21%-470.47%-235.61%-726.67%-143.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.176.7727.4028.4360.76152.99